157 related articles for article (PubMed ID: 36246921)
1. Distinguishing between metastatic and benign adrenal masses in patients with extra-adrenal malignancies.
Chen J; He Y; Zeng X; Zhu S; Li F
Front Endocrinol (Lausanne); 2022; 13():978730. PubMed ID: 36246921
[TBL] [Abstract][Full Text] [Related]
2. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of benign percutaneous adrenal biopsies in oncology patients.
Harisinghani MG; Maher MM; Hahn PF; Gervais DA; Jhaveri K; Varghese J; Mueller PR
Clin Radiol; 2002 Oct; 57(10):898-901. PubMed ID: 12413913
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Takeuchi M; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2016 Nov; 207(5):1031-1038. PubMed ID: 27556736
[TBL] [Abstract][Full Text] [Related]
5. Iodine and Fat Quantification for Differentiation of Adrenal Gland Adenomas From Metastases Using Third-Generation Dual-Source Dual-Energy Computed Tomography.
Martin SS; Weidinger S; Czwikla R; Kaltenbach B; Albrecht MH; Lenga L; Vogl TJ; Wichmann JL
Invest Radiol; 2018 Mar; 53(3):173-178. PubMed ID: 28990974
[TBL] [Abstract][Full Text] [Related]
6. [Computerized tomography findings score in the differentiation of adrenal tumors in patients with extra-adrenal malignomas].
Gufler H; Buitrago-Tellez CH; Laubenberger J; Tanyü MO; Mundinger A
Rofo; 1996 Aug; 165(2):118-22. PubMed ID: 8924662
[TBL] [Abstract][Full Text] [Related]
7. Adrenal metastases: early biphasic contrast-enhanced CT findings with emphasis on differentiation from lipid-poor adrenal adenomas.
Zhu F; Zhu X; Shi H; Liu C; Xu Z; Shao M; Tian F; Wang J
Clin Radiol; 2021 Apr; 76(4):294-301. PubMed ID: 33509608
[TBL] [Abstract][Full Text] [Related]
8. Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
Guerin C; Pattou F; Brunaud L; Lifante JC; Mirallié E; Haissaguerre M; Huglo D; Olivier P; Houzard C; Ansquer C; Hindié E; Loundou A; Archange C; Tabarin A; Sebag F; Baumstarck K; Taïeb D
J Clin Endocrinol Metab; 2017 Jul; 102(7):2465-2472. PubMed ID: 28431167
[TBL] [Abstract][Full Text] [Related]
9. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG-PET/CT Evaluation of Indeterminate Adrenal Masses in Noncancer Patients.
He X; Caoili EM; Avram AM; Miller BS; Else T
J Clin Endocrinol Metab; 2021 Apr; 106(5):1448-1459. PubMed ID: 33524123
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models.
Ng CS; Wei W; Altinmakas E; Li X; Ghosh P; Perrier NA; Grubbs E; Prieto VG; Lee JE; Hobbs BP
AJR Am J Roentgenol; 2018 Apr; 210(4):W156-W163. PubMed ID: 29412015
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing metastases from benign adrenal masses: what can CT texture analysis do?
Shi B; Zhang GM; Xu M; Jin ZY; Sun H
Acta Radiol; 2019 Nov; 60(11):1553-1561. PubMed ID: 30799636
[No Abstract] [Full Text] [Related]
13. Predictive factors for adrenal metastasis in extra-adrenal malignancy patients with solitary adrenal mass.
Byeon KH; Ha YS; Choi SH; Kim BS; Kim HT; Yoo ES; Kwon TG; Lee JN; Kim TH
J Surg Oncol; 2018 Dec; 118(8):1271-1276. PubMed ID: 30367684
[TBL] [Abstract][Full Text] [Related]
14. Adrenal tumors: how to establish malignancy ?
Fassnacht M; Kenn W; Allolio B
J Endocrinol Invest; 2004 Apr; 27(4):387-99. PubMed ID: 15233562
[TBL] [Abstract][Full Text] [Related]
15. Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement.
Kim JY; Kim SH; Lee HJ; Kim MJ; Kim YH; Cho SH; Won KS
Br J Radiol; 2013 Aug; 86(1028):20130190. PubMed ID: 23833032
[TBL] [Abstract][Full Text] [Related]
16. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone?
Song JH; Grand DJ; Beland MD; Chang KJ; Machan JT; Mayo-Smith WW
AJR Am J Roentgenol; 2013 Dec; 201(6):1248-53. PubMed ID: 24261363
[TBL] [Abstract][Full Text] [Related]
17. Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?
Ho LM; Samei E; Mazurowski MA; Zheng Y; Allen BC; Nelson RC; Marin D
AJR Am J Roentgenol; 2019 Mar; 212(3):554-561. PubMed ID: 30620676
[TBL] [Abstract][Full Text] [Related]
18. (18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients.
Sung YM; Lee KS; Kim BT; Choi JY; Chung MJ; Shim YM; Yi CA; Kim TS
Korean J Radiol; 2008; 9(1):19-28. PubMed ID: 18253072
[TBL] [Abstract][Full Text] [Related]
19. The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer.
Gillams A; Roberts CM; Shaw P; Spiro SG; Goldstraw P
Clin Radiol; 1992 Jul; 46(1):18-22. PubMed ID: 1643776
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
